iPS cell technologies and their prospect for bone regeneration and disease modeling: A mini review

Filomeno, 2012, Stem cell research and clinical development in tendon repair, Muscles Ligaments Tendons J, 2, 204 Xin, 2010, Aging adversely impacts biological properties of human bone marrow-derived mesenchymal stem cells: implications for tissue engineering heart valve construction, Artif Organs, 34, 215, 10.1111/j.1525-1594.2009.00824.x Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 Deng, 2010, Induced pluripotent stem cells: path to new medicine, EMBRO Rep, 11, 161, 10.1038/embor.2010.15 Tanabe, 2014, Induction of pluripotency by defined factors, Proc Jpn Acad Ser B Phys Biol Sci, 90, 83, 10.2183/pjab.90.83 Sabapathy, 2016, HiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine, J Cell Mol Med, 20, 1571, 10.1111/jcmm.12839 Okita, 2008, Generation of mouse induced pluripotent stem cells without viral vectors, Science, 322, 949, 10.1126/science.1164270 Iglesias-García, 2013, Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling, J Mol Cell Cardiol, 62, 43, 10.1016/j.yjmcc.2013.04.022 Singh, 2015, Mechanism of induction: Induced pluripotent stem cells (iPSCs), J Stem Cells, 10, 43 Kim, 2009, Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs, J Gene Med, 11, 791, 10.1002/jgm.1352 Ji, 2016, Induced pluripotent stem cells: generation strategy and epigenetic mystery behind reprogramming, Stem Cells Int, 2016, 8415010, 10.1155/2016/8415010 Miyoshi, 2011, Reprogramming of mouse and human cells to pluripotency using mature microRNAs, Cell Stem Cell, 8, 633, 10.1016/j.stem.2011.05.001 Li, 2012, Identification of Oct4-activating compounds that enhance reprogramming efficiency, Proc Natl Acad Sci USA, 109, 20853, 10.1073/pnas.1219181110 Li, 2016, Optimized approaches for generation of integration-free iPSCs from human urine-derived cells with small molecules and autologous feeder, Stem Cell Rep, 6, 717, 10.1016/j.stemcr.2016.04.001 Mikami, 2014, Current status of drug therapies for osteoporosis and the search for stem cells adapted for bone regenerative medicine, Anat Sci Int, 89, 1, 10.1007/s12565-013-0208-8 Egusa, 2012, IPS cells in dentistry, Clin Calcium, 22, 67 Dimitriou, 2011, Complications following autologous bone graft harvesting from the iliac crest and using the RIA: a systematic review, Injury, 42, S3, 10.1016/j.injury.2011.06.015 de Peppo, 2013, Engineering bone tissue substitutes from human induced pluripotent stem cells, Proc Natl Acad Sci USA, 110, 8680, 10.1073/pnas.1301190110 Xie, 2016, Osteogenic differentiation and bone regeneration of iPSC-MSCs supported by a biomimetic nanofibrous scaffold, Acta Biomater, 29, 365, 10.1016/j.actbio.2015.10.007 Ardeshirylajimi, 2014, A comparative study of osteogenic differentiation human induced pluripotent stem cells and adipose tissue derived mesenchymal stem cells, Cell J, 16, 235 Chen, 2014, The use of patient-specific induced pluripotent stem cells (iPSCs) to identify osteoclast defects in rare genetic bone disorders, J Clin Med, 3, 1490, 10.3390/jcm3041490 Wu, 2016, Deriving osteogenic cells from induced pluripotent stem cells for bone tissue engineering, Tissue Eng Part B Rev Lou, 2015, Induced pluripotent stem cells as a new strategy for osteogenesis and bone regeneration, Stem Cell Rev, 11, 645, 10.1007/s12015-015-9594-8 Wang, 2015, In vitro culture and directed osteogenic differentiation of human pluripotent stem cells on peptides-decorated two-dimensional microenvironment, ACS Appl Mater Interf, 7, 4560, 10.1021/acsami.5b00188 Kumaran, 2010, Osteoblast response to commercially available demineralized bone matrices – an in-vitro study, Indian J Dent Res, 21, 3, 10.4103/0970-9290.62796 Li, 2012, Cells derived from murine induced pluripotent stem cells (iPSC) by treatment with members of TGF-beta family give rise to osteoblasts differentiation and form bone in vivo, BMC Cell Biol, 13, 35, 10.1186/1471-2121-13-35 Bilousova, 2011, Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vivo, Stem cells, 29, 206, 10.1002/stem.566 Tashiro, 2009, Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction, Stem cells, 27, 1802, 10.1002/stem.108 Illich, 2011, Concise review: induced pluripotent stem cells and lineage reprogramming: prospects for bone regeneration, Stem cells, 29, 555, 10.1002/stem.611 Heng, 2008, An autologous cell lysate extract from human embryonic stem cell (hESC) derived osteoblasts can enhance osteogenesis of hESC, Tissue Cell, 40, 219, 10.1016/j.tice.2007.12.003 Teng, 2014, The application of induced pluripotent stem cells for bone regeneration: current progress and prospects, Tissue Eng Part B Rev, 20, 328, 10.1089/ten.teb.2013.0301 Kao, 2010, Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells, Stem Cells Dev, 19, 247, 10.1089/scd.2009.0186 Ji, 2016, Patient-derived human induced pluripotent stem cells from gingival fibroblasts composited with defined nanohydroxyapatite/chitosan/gelatin porous scaffolds as potential bone graft substitutes, Stem Cells Transl Med, 5, 95, 10.5966/sctm.2015-0139 Kang, 2016, Small molecule-driven direct conversion of human pluripotent stem cells into functional osteoblasts, Sci Adv, 2, e1600691, 10.1126/sciadv.1600691 Xin, 2009, Bioactive SrTiO(3) nanotube arrays: strontium delivery platform on Ti-based osteoporotic bone implants, ACS Nano, 3, 3228, 10.1021/nn9007675 Jin, 2013, Bone tissue engineering of induced pluripotent stem cells cultured with macrochanneled polymer scaffold, J Biomed Mater Res A, 101, 1283, 10.1002/jbm.a.34425 Phadke, 2012, Mineralized synthetic matrices as an instructive microenvironment for osteogenic differentiation of human mesenchymal stem cells, Macromol Biosci, 12, 1022, 10.1002/mabi.201100289 Vaquette, 2013, Effect of culture conditions and calcium phosphate coating on ectopic bone formation, Biomaterials, 34, 5538, 10.1016/j.biomaterials.2013.03.088 Kang, 2014, Mineralized gelatin methacrylate-based matrices induce osteogenic differentiation of human induced pluripotent stem cells, Acta Biomater, 10, 4961, 10.1016/j.actbio.2014.08.010 Levi, 2012, In vivo directed differentiation of pluripotent stem cells for skeletal regeneration, Proc Natl Acad Sci USA, 109, 20379, 10.1073/pnas.1218052109 Ardeshirylajimi, 2015, Enhanced growth and osteogenic differentiation of induced pluripotent stem cells by extremely low-frequency electromagnetic field, Cell Mol Biol (Noisy-le-grand), 61, 36 Zou, 2016, Angiogenic activity mediates bone repair from human pluripotent stem cell-derived osteogenic cells, Sci Rep, 6, 22868, 10.1038/srep22868 Barruet, 2016, Using human induced pluripotent stem cells to model skeletal diseases, Methods Mol Biol, 1353, 101, 10.1007/7651_2014_171 Saitta, 2014, Patient-derived skeletal dysplasia induced pluripotent stem cells display abnormal chondrogenic marker expression and regulation by BMP2 and TGFβ1, Stem Cells Dev, 23, 1464, 10.1089/scd.2014.0014 Matsumoto, 2013, Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation, Orphanet J Rare Dis, 8, 190, 10.1186/1750-1172-8-190 Matsumoto, 2015, New protocol to optimize iPS cells for genome analysis of fibrodysplasia ossificans progressiva, Stem Cells, 33, 1730, 10.1002/stem.1981 Hildebrand, 2016, The Fibrodysplasia Ossificans Progressiva (FOP) mutation p. R206H in ACVR1 confers an altered ligand response, Cell Signal, 29, 23, 10.1016/j.cellsig.2016.10.001 Barruet, 2016, The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling, Stem Cell Res Ther, 7, 115, 10.1186/s13287-016-0372-6 Hu, 2013, A novel autosomal recessive GJA1 missense mutation linked to craniometaphyseal dysplasia, PLoS ONE, 12, e73576, 10.1371/journal.pone.0073576 Quarto, 2012, Skeletogenic phenotype of human Marfan embryonic stem cells faithfully phenocopied by patient-specific induced-pluripotent stem cells, Proc Natl Acad Sci USA, 109, 215, 10.1073/pnas.1113442109 Ramachandra, 2015, Molecular pathogenesis of Marfan syndrome, Int J Cardiol, 187, 585, 10.1016/j.ijcard.2015.03.423 Stadtfeld, 2010, Induced pluripotency: history, mechanisms, and applications, Genes Dev, 24, 2239, 10.1101/gad.1963910 Zhou, 2009, Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells, Stem cells, 27, 2667, 10.1002/stem.201 Yu, 2009, Human induced pluripotent stem cells free of vector and transgene sequences, Science, 324, 797, 10.1126/science.1172482 Chou, 2011, Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures, Cell Res, 21, 518, 10.1038/cr.2011.12 Jia, 2010, A nonviral minicircle vector for deriving human iPS cells, Nat Methods, 7, 197, 10.1038/nmeth.1426 Woltjen, 2009, PiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells, Nature, 458, 766, 10.1038/nature07863 Ban, 2011, Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors, Proc Natl Acad Sci USA, 108, 14234, 10.1073/pnas.1103509108 Nakanishi, 2012, Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine, Curr Gene Ther, 12, 410, 10.2174/156652312802762518 Kim, 2009, Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins, Cell Stem Cell, 4, 472, 10.1016/j.stem.2009.05.005 Warren, 2010, Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA, Cell Stem Cell, 7, 618, 10.1016/j.stem.2010.08.012 Zhang, 2012, Small molecules, big roles – the chemical manipulation of stem cell fate and somatic cell reprogramming, J Cell Sci, 125, 5609, 10.1242/jcs.096032 Brooke, 2008, Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta, Stem Cells Dev, 17, 929, 10.1089/scd.2007.0156 Schimke, 2015, Patient-specific age: the other side of the coin in advanced mesenchymal stem cell therapy, Front Physiol, 6, 362, 10.3389/fphys.2015.00362 Sheyn, 2016, Human iPSCs differentiate into functional MSCs and repair bone defects, Stem Cells Transl Med, 5, 1447, 10.5966/sctm.2015-0311 Wang, 2015, Bone tissue engineering via human induced pluripotent, umbilical cord and bone marrow mesenchymal stem cells in rat cranium, Acta Biomater, 18, 236, 10.1016/j.actbio.2015.02.011 Lian, 2010, Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice, Circulation, 121, 1113, 10.1161/CIRCULATIONAHA.109.898312 Murphy, 2013, Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine, Exp Mol Med, 45, e54, 10.1038/emm.2013.94 Stoltz, 2015, Stem Cells and regenerative medicine: myth or reality of the 21th Century, Stem Cells Int, 2015, 734731, 10.1155/2015/734731 Bastami, 2017, Induced pluripotent stem cells as a new getaway for bone tissue engineering: a systematic review, Cell Prolif, 50, e12321, 10.1111/cpr.12321